Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh.
Chowdhury F, Ali Syed K, Akter A, Rahman Bhuiyan T, Tauheed I, Khaton F, Biswas R, Ferdous J, Al Banna H, Ross AG, Mc Millan N, Sharma T, Kanchan V, Pal Singh A, Gill D, Lebens M, Nordqvist S, Holmgren J, Clemens JD, Qadri F. Chowdhury F, et al. Among authors: lebens m. Vaccine. 2021 Jul 22;39(32):4450-4457. doi: 10.1016/j.vaccine.2021.06.069. Epub 2021 Jul 1. Vaccine. 2021. PMID: 34218960 Free article. Clinical Trial.
Immune responses against oxidized LDL as possible targets for prevention of atherosclerosis in systemic lupus erythematosus.
Yao Mattisson I, Rattik S, Björkbacka H, Ljungcrantz I, Terrinoni M, Lebens M, Holmgren J, Fredrikson GN, Gullstrand B, Bengtsson AA, Nilsson J, Wigren M. Yao Mattisson I, et al. Among authors: lebens m. Vascul Pharmacol. 2021 Oct;140:106863. doi: 10.1016/j.vph.2021.106863. Epub 2021 Apr 15. Vascul Pharmacol. 2021. PMID: 33857652 Free article.
Development of Hillchol®, a low-cost inactivated single strain Hikojima oral cholera vaccine.
Sharma T, Joshi N, Kumar Mandyal A, Nordqvist SL, Lebens M, Kanchan V, Löfstrand M, Jeverstam F, Mainul Ahasan M, Khan I, Karim M, Muktadir H, Muktadir A, Gill D, Holmgren J. Sharma T, et al. Among authors: lebens m. Vaccine. 2020 Nov 25;38(50):7998-8009. doi: 10.1016/j.vaccine.2020.10.043. Epub 2020 Oct 31. Vaccine. 2020. PMID: 33139137 Free article.
A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors.
Tobias J, Battin C, De Sousa Linhares A, Lebens M, Baier K, Ambroz K, Drinić M, Högler S, Inic-Kanada A, Garner-Spitzer E, Preusser M, Kenner L, Kundi M, Zielinski CC, Steinberger P, Wiedermann U. Tobias J, et al. Among authors: lebens m. Front Immunol. 2020 May 27;11:895. doi: 10.3389/fimmu.2020.00895. eCollection 2020. Front Immunol. 2020. PMID: 32528470 Free PMC article.
Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines.
Davitt CJH, Longet S, Albutti A, Aversa V, Nordqvist S, Hackett B, McEntee CP, Rosa M, Coulter IS, Lebens M, Tobias J, Holmgren J, Lavelle EC. Davitt CJH, et al. Among authors: lebens m. Mucosal Immunol. 2019 Jul;12(4):1055-1064. doi: 10.1038/s41385-019-0159-z. Epub 2019 Apr 5. Mucosal Immunol. 2019. PMID: 30953000 Free PMC article.
61 results